Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1291 AL 1305

Anticoagulant prescribing for atrial fibrillation and risk of incident dementia

Cadogan SL, Powell E, Wing K, Wong AY, Smeeth L, Warren-Gash C.

Heart. 2021 Dec;107(23):1898-1904. doi: 10.1136/heartjnl-2021-319672. Epub 2021 Oct 13.

Cognitive Dysfunction in Cats: Update on Neuropathological and Behavioural Changes Plus Clinical Management

Sordo L, Gunn-Moore DA.

Vet Rec. 2021 Jan;188(1):e3. doi: 10.1002/vetr.3. Epub 2021 Jan 12.

Going round in circles-The Papez circuit in Alzheimer's disease

Forno G, Lladó A, Hornberger M.

Eur J Neurosci. 2021 Nov;54(10):7668-7687. doi: 10.1111/ejn.15494. Epub 2021 Nov 2.

Electrocardiographic Predictors of Cognitive Decline and Dementia: A Systematic Review

Imahori Y, Vetrano DL, Ljungman P, Qiu C.

J Alzheimers Dis. 2021;84(3):1303-1322. doi: 10.3233/JAD-210606.

Erzhi pills ameliorate cognitive dysfunction and alter proteomic hippocampus profiles induced by d-galactose and Aβ(1-)(40) injection in ovariectomized Alzheimer's disease model rats

Xie Y, Yan B, Hou M, Zhou M, Liu C, Sun M, He K, Fang C, Chen Y, Huang L.

Pharm Biol. 2021 Dec;59(1):1402-1414. doi: 10.1080/13880209.2021.1990353.

Speech and language impairments in behavioral variant frontotemporal dementia: A systematic review

Geraudie A, Battista P, García AM, Allen IE, Miller ZA, Gorno-Tempini ML, Montembeault M.

Neurosci Biobehav Rev. 2021 Dec;131:1076-1095. doi: 10.1016/j.neubiorev.2021.10.015. Epub 2021 Oct 19.

Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1

Liu XY, Zhang N, Zhang SX, Xu P.

Eur J Neurosci. 2021 Nov;54(10):7749-7769. doi: 10.1111/ejn.15502. Epub 2021 Nov 7.

MicroRNA-455-5p/CPEB1 pathway mediates Aβ-related learning and memory deficits in a mouse model of Alzheimer's disease

Xiao G, Chen Q, Zhang X.

Brain Res Bull. 2021 Dec;177:282-294. doi: 10.1016/j.brainresbull.2021.10.008. Epub 2021 Oct 20.

Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer's Disease

Flores-Clemente C, Nicolás-Vázquez MI, Mera Jiménez E, Hernández-Rodríguez M.

Biomolecules. 2021 Sep 26;11(10):1408. doi: 10.3390/biom11101408.

Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

Banerjee S, High J, Stirling S, Shepstone L, Swart AM, Telling T, Henderson C, Ballard C, Bentham P, Burns A, Farina N, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Tabet N.

Lancet. 2021 Oct 23;398(10310):1487-1497. doi: 10.1016/S0140-6736(21)01210-1.

Language changes in Alzheimer's disease: A systematic review of verb processing

Williams E, McAuliffe M, Theys C.

Brain Lang. 2021 Dec;223:105041. doi: 10.1016/j.bandl.2021.105041. Epub 2021 Oct 21.

Heterogeneity in Reports of Dementia Disease Duration and Severity: A Review of the Literature

Brück CC, Wolters FJ, Ikram MA, de Kok IMCM.

J Alzheimers Dis. 2021;84(4):1515-1522. doi: 10.3233/JAD-210544.

Lifespace metrics of older adults with mild cognitive impairment and dementia recorded via geolocation data

Liddle J, Ireland D, Krysinska K, Harrison F, Lamont R, Karunanithi M, Kang K, Reppermund S, Sachdev PS, Gustafsson L, Brauer S, Pachana NA, Brodaty H.

Australas J Ageing. 2021 Dec;40(4):e341-e346. doi: 10.1111/ajag.13007. Epub 2021 Oct 26.

Efficacy of non-invasive brain stimulation on global cognition and neuropsychiatric symptoms in Alzheimer's disease and mild cognitive impairment: A meta-analysis and systematic review

Teselink J, Bawa KK, Koo GK, Sankhe K, Liu CS, Rapoport M, Oh P, Marzolini S, Gallagher D, Swardfager W, Herrmann N, Lanctôt KL.

Ageing Res Rev. 2021 Dec;72:101499. doi: 10.1016/j.arr.2021.101499. Epub 2021 Oct 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias